{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:26:02Z","timestamp":1767666362102},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T00:00:00Z","timestamp":1231286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00296-008-0833-z","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T06:29:34Z","timestamp":1231223374000},"page":"431-436","source":"Crossref","is-referenced-by-count":19,"title":["Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis"],"prefix":"10.1007","volume":"29","author":[{"given":"Katsuya","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiko","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroe","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensei","family":"Tsuzaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,7]]},"reference":[{"key":"833_CR1","doi-asserted-by":"crossref","unstructured":"O\u2019Dell JR (2004) Therapeutic strategies for rheumatoid arthritis. N Engl J Med 17;350(25):2591\u2013602","DOI":"10.1056\/NEJMra040226"},{"issue":"6","key":"833_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7(6):429\u2013442. doi: 10.1038\/nri2094","journal-title":"Nat Rev Immunol"},{"issue":"16","key":"833_CR3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2169\/internalmedicine.46.1913","volume":"46","author":"T Takeuchi","year":"2007","unstructured":"Takeuchi T (2007) Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis. Intern Med 46(16):1311\u20131312. doi: 10.2169\/internalmedicine.46.1913","journal-title":"Intern Med"},{"issue":"5","key":"833_CR4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0952-7915(92)90024-9","volume":"4","author":"JJ Siekierka","year":"1992","unstructured":"Siekierka JJ, Sigal NH (1992) FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond. Curr Opin Immunol 4(5):548\u2013552. doi: 10.1016\/0952-7915(92)90024-9","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"833_CR5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/sj.bjp.0703472","volume":"130","author":"S Sakuma","year":"2000","unstructured":"Sakuma S, Kato Y, Nishigaki F, Sasakawa T, Magari K, Miyata S, Ohkubo Y, Goto T (2000) FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells. Br J Pharmacol 130(7):1655\u20131663. doi: 10.1038\/sj.bjp.0703472","journal-title":"Br J Pharmacol"},{"issue":"4","key":"833_CR6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1567-5769(01)00008-X","volume":"1","author":"S Sakuma","year":"2001","unstructured":"Sakuma S, Kato Y, Nishigaki F, Magari K, Miyata S, Ohkubo Y, Goto T (2001) Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro. Int Immunopharmacol 1(4):749\u2013757. doi: 10.1016\/S1567-5769(01)00008-X","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"833_CR7","first-page":"2332","volume":"26","author":"RB Gremillion","year":"1999","unstructured":"Gremillion RB, Posever JO, Manek N, West JP, van Volen-Hoven RF (1999) Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis: initial experience in 12 patients. J Rheumatol 26(11):2332\u20132336","journal-title":"J Rheumatol"},{"issue":"8","key":"833_CR8","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/art.10427","volume":"46","author":"DE Furst","year":"2002","unstructured":"Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA (2002) Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study. Arthritis Rheum 46(8):2020\u20132028. doi: 10.1002\/art.10427","journal-title":"Arthritis Rheum"},{"issue":"10","key":"833_CR9","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/art.11257","volume":"48","author":"JM Kremer","year":"2003","unstructured":"Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group (2003) Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study. Arthritis Rheum 48(10):2763\u20132768. doi: 10.1002\/art.11257","journal-title":"Arthritis Rheum"},{"issue":"12","key":"833_CR10","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1002\/art.11363","volume":"48","author":"DE Yocum","year":"2003","unstructured":"Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus Rheumatoid Arthritis Study Group (2003) Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum 48(12):3328\u20133337. doi: 10.1002\/art.11363","journal-title":"Arthritis Rheum"},{"issue":"2","key":"833_CR11","first-page":"243","volume":"31","author":"H Kondo","year":"2004","unstructured":"Kondo H, Abe T, Hashimoto H, Uchida S, Irimajiri S, Hara M, Sugawara S (2004) Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study. J Rheumatol 31(2):243\u2013251","journal-title":"J Rheumatol"},{"issue":"8","key":"833_CR12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/rheumatology\/keh155","volume":"43","author":"DE Yocum","year":"2004","unstructured":"Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA, Tacrolimus RA Study Group (2004) Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience. Rheumatology 43(8):992\u2013999. doi: 10.1093\/rheumatology\/keh155","journal-title":"Rheumatology"},{"issue":"4","key":"833_CR13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kei172","volume":"45","author":"S Kawai","year":"2006","unstructured":"Kawai S, Yamamoto K (2006) Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients. Rheumatology 45(4):441\u2013444. doi: 10.1093\/rheumatology\/kei172","journal-title":"Rheumatology"},{"issue":"11","key":"833_CR14","first-page":"2153","volume":"33","author":"S Kawai","year":"2006","unstructured":"Kawai S, Hashimoto H, Kondo H, Murayama T, Kiuchi T, Abe T (2006) Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis. J Rheumatol 33(11):2153\u20132161","journal-title":"J Rheumatol"},{"issue":"7","key":"833_CR15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00003495-200565070-00005","volume":"65","author":"MP Curran","year":"2005","unstructured":"Curran MP, Perry CM (2005) Tacrolimus: in patients with rheumatoid arthritis. Drugs 65(7):993\u20131001. doi: 10.2165\/00003495-200565070-00005","journal-title":"Drugs"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-008-0833-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0833-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:16:14Z","timestamp":1559042174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-008-0833-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s00296-008-0833-z","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,7]]}}}